Intensifying competition, pricing pressure and copycat versions of Ozempic and Wegovy hold back sales at the pharma giant.

As Ozempic use rises, society’s obsession with thinness is erasing body positivity and real, authentic bodies.

Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.

A Shocking Reality The fashion industry's relationship with body diversity is like a bad breakup – it keeps promising change ...